This document discusses drug promotion and advertising practices. It notes that drug companies use various marketing tactics like journal advertisements, mailings, company representative visits, gifts, and sponsorships to promote their drugs. It outlines guidelines for medical representatives' interactions with clinicians and cautions that information from representatives can be misleading and increase costs. The document advises critically appraising promotional materials by examining the supporting evidence, wording, appeals, graphics, and claims made. It provides tips for health care practitioners to maintain a skeptical view of drug promotion and make informed prescribing decisions based on evidence, not marketing influence.
2. Drug Promotion/Advertisement
Journal advertisements
Mailings
Company representative visits
Gifts ( medical samples , cash , personal gifts , cultural courtesy gifts ,
promotional aids, reminder items , medical utility items )
Sponsorships ( travel , meals , accommodation, registration fees)
Direct-to-consumer advertising
2
3. Traits of a medical representative
Must be adequately trained
Must not give misleading information
Must not offer inducement to gain interview
Must not cause inconvenience
Provision of hospitality
3
4. Guidelines for MRs
Appointment system for meeting clinicians
Leaving samples of medicines
Sponsorship of educational meetings
Frequency of meetings
4
5. Meeting with Medical representative
What’s in it for me?
Be selective
By appointment with time limits
Be in control
Prepare standard questions
Beware of bold statements
5
6. Information from representatives
Can be misleading
Promotes non-rational prescribing
Decreases generic prescribing
Increases awareness of new drugs but without the
evidence
Increases prescribing costs
6
7. Oral presentations
At least one inaccurate fact in 81% of presentations
On average, at least 11% of statements made in an oral
presentation maybe inaccurate
All inaccuracies are likely to favour promotion of the
drug
7
8. Critical Appraisal
Supporting Evidence
Words and phrases
Appeal to Authority
Colours, pictures and emotion
Graphs
8
9. Written literature
Protocols as evidence of clinical benefits
Publication in non-peer reviewed / obscure journals
Graphs with misleading axes!
Surrogate endpoints
Claims of superior potency
Data from in-vitro studies, healthy volunteers
Claims from emerging or scientific opinions
Price comparisons
Statistics
9
10. What printed material should contain:
Name of the product
Active ingredient
Name and address of manufaturer
Date of production
Abbreviated prescribing information
10
13. Commonly misused shortcuts for
choosing therapies
Newer is better
Experts know best
If there is a mechanism for how a drug works, then it works
If my peers are prescribing the drug then so should I.
If the patient improves after the drug is prescribed, then the
therapy must have worked.
If the manufacturer gives gifts, I should support them in return
13
18. Drug companies know how to manipulate
our main motivations
Burnt out Dodo
Caring Bunny
Conservative Sheep
Entrepreneurial Wolf
Branthwaite A, Downing T.
Marketing to doctors – the
human factor. Scrip Magazine
1995 March;32-5
18
19. Your ability to cope with potentially
misleading promotion depends on your
understanding of:
Medicine
Pharmacology, Epidemiology, Public Health, Evidence Based Medicine,
Drug Evaluation, Pharmacovigilance
Social sciences
Psychology, Economics, Sociology, Anthropology, Management,
History, Politics, Communication Studies,
Humanities
Logic, Rhetoric,Linguistics, Literature, Art
Marketing
Product Management, Advertising Account Planning, Public Relations
Statistics
19